Rami Levy - INC Research Chief Canndoc

INCR Stock  USD 1.42  0.07  5.19%   

Insider

Rami Levy is Chief Canndoc of INC Research Holdings
Age 59
Address 85 Medinat ha-Yehudim Street, Herzliya, Israel, 4676670
Phone972 7 746 05012
Webhttps://www.intercure.co

INC Research Management Efficiency

As of 11/25/2024, Return On Tangible Assets is likely to drop to -0.12. In addition to that, Return On Capital Employed is likely to grow to -0.07. At this time, INC Research's Total Assets are relatively stable compared to the past year. As of 11/25/2024, Non Current Assets Total is likely to grow to about 386.2 M, while Return On Tangible Assets are likely to drop (0.12). INC Research's management efficiency ratios could be used to measure how well INC Research manages its routine affairs as well as how well it operates its assets and liabilities.
INC Research Holdings currently holds 195.68 M in liabilities with Debt to Equity (D/E) ratio of 0.32, which is about average as compared to similar companies. INC Research Holdings has a current ratio of 1.83, which is within standard range for the sector. Note, when we think about INC Research's use of debt, we should always consider it together with its cash and equity.

Similar Executives

Showing other executives

INSIDER Age

Julianna CFAVerano Holdings Corp
N/A
Eric OffenbergerVext Science
N/A
Anya VargaAYR Strategies Class
N/A
Darren EsqVerano Holdings Corp
39
Scott SudduthCollegium Pharmaceutical
N/A
Aaron MilesVerano Holdings Corp
44
Jonathan MDPacira BioSciences,
49
David SpreckmanVerano Holdings Corp
33
Damian FinioPhibro Animal Health
54
Samuel DorfVerano Holdings Corp
N/A
Daryl GauglerPacira BioSciences,
62
Richard MDCollegium Pharmaceutical
64
George ArchosVerano Holdings Corp
44
Jeffrey ZerilloPrestige Brand Holdings
63
Adel MekhailPrestige Brand Holdings
63
Wai ChungRegencell Bioscience Holdings
47
Jeff FinnertyAYR Strategies Class
N/A
Jason NguyenVext Science
N/A
Alex DasallaCollegium Pharmaceutical
N/A
Robert VaniskoAYR Strategies Class
N/A
Philip TerpolilliPrestige Brand Holdings
N/A
InterCure Ltd., together with its subsidiaries, engages in the research, cultivation, production, marketing, and distribution of medical cannabis products in Israel and internationally. InterCure Ltd. was incorporated in 1994 and is headquartered in Herzliya, Israel. Intercure operates under Drug ManufacturersSpecialty Generic classification in the United States and is traded on NASDAQ Exchange. It employs 350 people. INC Research Holdings (INCR) is traded on NASDAQ Exchange in USA. It is located in 85 Medinat ha-Yehudim Street, Herzliya, Israel, 4676670 and employs 270 people. INC Research is listed under Biotechnology category by Fama And French industry classification.

Management Performance

INC Research Holdings Leadership Team

Elected by the shareholders, the INC Research's board of directors comprises two types of representatives: INC Research inside directors who are chosen from within the company, and outside directors, selected externally and held independent of INC. The board's role is to monitor INC Research's management team and ensure that shareholders' interests are well served. INC Research's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, INC Research's outside directors are responsible for providing unbiased perspectives on the board's policies.
Alexander Rabinovich, CEO Director
Amos Cohen, Chief Officer
Alexander Rabinovitch, CEO Director
Advocate Ohayon, CoFounder Ltd
Einat Zehavi, Vice Sales
OriMoni Mimon, CoFounder Ltd
Omri Batzir, Corporate Controller
Rami Levy, Chief Canndoc

INC Stock Performance Indicators

The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is INC Research a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.

Pair Trading with INC Research

One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if INC Research position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in INC Research will appreciate offsetting losses from the drop in the long position's value.

Moving together with INC Stock

  0.78ME 23Andme HoldingPairCorr
  0.91VALN Valneva SE ADRPairCorr
  0.83JNJ Johnson Johnson Fiscal Year End 28th of January 2025 PairCorr

Moving against INC Stock

  0.57MDGL Madrigal PharmaceuticalsPairCorr
  0.48KZR Kezar Life SciencesPairCorr
  0.48RNXT RenovoRxPairCorr
  0.33NXGLW NexGel WarrantPairCorr
The ability to find closely correlated positions to INC Research could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace INC Research when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back INC Research - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling INC Research Holdings to buy it.
The correlation of INC Research is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as INC Research moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if INC Research Holdings moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for INC Research can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.
Pair CorrelationCorrelation Matching

Additional Tools for INC Stock Analysis

When running INC Research's price analysis, check to measure INC Research's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy INC Research is operating at the current time. Most of INC Research's value examination focuses on studying past and present price action to predict the probability of INC Research's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move INC Research's price. Additionally, you may evaluate how the addition of INC Research to your portfolios can decrease your overall portfolio volatility.